US Patent Issued to Dana-Farber Cancer Institute on Feb. 24 for "Compositions and methods of treating Fanconi Anemia" (Massachusetts Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,369, issued on Feb. 24, was assigned to Dana-Farber Cancer Institute Inc. (Boston).

"Compositions and methods of treating Fanconi Anemia" was invented by Alan D'Andrea (Winchester, Mass.), Kalindi Parmar (Arlington, Mass.) and Haojian Zhang (Shrewsbury, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods of treating, preventing or delaying the onset bone marrow failure in Fanconi Anemia patients."

The patent was filed on July 20, 2023, under Application No. 18/224,384.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOF...